Evidence map›Paper›PMID 33467039›Full record

ArticleMicromachines2021

Long-Term Human Hematopoietic Stem Cell Culture in Microdroplets.

Pilar Carreras, Itziar González, Miguel Gallardo, Alejandra Ortiz-Ruiz, Maria Luz Morales, Jessica Encinas, Joaquín Martínez-López

Open access · goldAbstract read
In one paragraph

Article in Micromachines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. 3DACS biomaterials science & engineering · 2026
    Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Pilar CarrerasCSIC, Spanish National Research Council, 28006 Madrid, Spain.
Itziar GonzálezCSIC, Spanish National Research Council, 28006 Madrid, Spain.ORCID 0000-0003-1814-5235
Miguel GallardoHospital 12 Octubre, Hematology Department, Research Institute i+12, 28040 Madrid, Spain.
Alejandra Ortiz-RuizHospital 12 Octubre, Hematology Department, Research Institute i+12, 28040 Madrid, Spain.ORCID 0000-0003-4059-8839
Maria Luz MoralesHospital 12 Octubre, Hematology Department, Research Institute i+12, 28040 Madrid, Spain.ORCID 0000-0002-0685-8441
Jessica EncinasHospital 12 Octubre, Hematology Department, Research Institute i+12, 28040 Madrid, Spain.ORCID 0000-0003-4479-9822
Joaquín Martínez-LópezHospital 12 Octubre, Hematology Department, Research Institute i+12, 28040 Madrid, Spain.ORCID 0000-0001-7908-0063
Research Institute Hospital 12 de Octubre · ESConsejo Superior de Investigaciones Científicas · ESUniversidad Complutense de Madrid · ES

Funding

European Commission 705163
6 · The paper itself

Abstract

We previously reported a new approach for micromanipulation and encapsulation of human stem cells using a droplet-based microfluidic device. This approach demonstrated the possibility of encapsulating and culturing difficult-to-preserve primary human hematopoietic stem cells using an engineered double-layered bead composed by an inner layer of alginate and an outer layer of Puramatrix. We also demonstrated the maintenance and expansion of Multiple Myeloma cells in this construction. Here, the presented microfluidic technique is applied to construct a 3D biomimetic model to recapitulate the human hematopoietic stem cell niche using double-layered hydrogel beads cultured in 10% FBS culture medium. In this model, the long-term maintenance of the number of cells and expansion of hHSCS encapsulated in the proposed structures was observed. Additionally, a phenotypic characterization of the human hematopoietic stem cells generated in the presented biomimetic model was performed in order to assess their long-term stemness maintenance. Results indicate that the ex vivo cultured human CD34+ cells from bone marrow were viable, maintained, and expanded over a time span of eight weeks. This novel long-term stem cell culture methodology could represent a novel breakthrough to improve Hematopoietic Progenitor cell Transplant (HPT) as well as a novel tool for further study of the biochemical and biophysical factors influencing stem cell behavior. This technology opens a myriad of new applications as a universal stem cell niche model potentially able to expand other types of cells.

Indexed as

Hematopoietic stem cellMicrodropletsMicrofluidicsStem cell culture

Identifiers

PMID33467039
PMCPMC7830102
OpenAlexW3123006239

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.